Q2 FY2026 · ended Jun 30, 2026 · Revenue $28.14M, +9.0% YoY · Filed Aug 11, 2026
Sanara Medtech Inc. (SMTI) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $28.1 million and a net loss of $452,864. Free cash flow was $2.0 million. As of Jun 30, 2026 it held $29.2 million in cash and investments and $48.5 million in total debt.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- SMTI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Fort Worth, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 714256
- Former names
- WOUND MANAGEMENT TECHNOLOGIES, INC. (until Apr 3, 2019); MB SOFTWARE CORP (until Jun 10, 2008); INAV TRAVEL CORPORATION (until May 3, 1996)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $28.1M | $27.8M | $27.5M | $26.3M | $25.8M |
| Operating income | $1.8M | $2.6M | $1.1M | $2.9M | $2.5M |
| Net income | -$452,864 | $458,957 | -$1.6M | -$30.4M | -$2.0M |
| Diluted EPS | -$0.05 | $0.05 | -$0.21 | -$3.40 | -$0.23 |
| Operating cash flow | $2.0M | -$2.5M | $3.9M | $2.2M | $2.7M |
| Free cash flow | $2.0M | -$2.5M | $3.9M | $1.1M | $902,652 |
| Total assets | $69.1M | $69.3M | $72.9M | $71.1M | $98.8M |
| Total liabilities | $61.2M | $62.3M | $67.0M | $64.9M | $63.4M |
| Stockholders' equity | $7.9M | $7.0M | $5.9M | $6.1M | $35.4M |
| Cash and investments | $29.2M | $27.8M | $31.2M | $27.5M | $27.5M |
| Total debt | $48.5M | $48.4M | $48.2M | $47.4M | $45.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Oct 1, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Aug 11, 2026 | Jul 29, 2026 |
All 737 Sanara Medtech Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.